Evidence map›Paper›PMID 34974994›Full record

ArticlePrimary care diabetes2022

Impact of COVID-19 lockdown on people living with diabetes: Experience from a low-middle income country in South Asia.

Harsha Dissanayake, Pasindu Soysa, Thilina Samarathunga, Laksara De Silva, Nadeesh Samaranayake, Chanya Padmaperuma, Prasad Katulanda

Open access · greenAbstract read
In one paragraph

Article in Primary care diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Harsha DissanayakeDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka. Electronic address: harsha@clinmed.cmb.ac.lk.
Pasindu SoysaDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka. Electronic address: pasindunilupulsoysa@gmail.com.
Thilina SamarathungaDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka. Electronic address: thilina.tas@gmail.com.
Laksara De SilvaDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka. Electronic address: laksaradesilva005ft@gmail.com.
Nadeesh SamaranayakeDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka. Electronic address: nadeesh89@gmail.com.
Chanya PadmaperumaMinistry of Health, Colombo, Sri Lanka. Electronic address: chanyapadmaperuma2@gmail.com.
Prasad KatulandaDiabetes Research Unit, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka; Department of Clinical Medicine, Faculty of Medicine, University of Colombo, 25 Kynsey Rd, Colombo 008, Sri Lanka; Cruddas Link Fellow, Harris Manchester College, University of Oxford, Oxford, UK. Electronic address: prasad.katulanda@clinmed.cmb.ac.lk.
University of Colombo · LKMinistry of Health, Nutrition and Indigenous Medicine · LKUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsCOVID-19 lockdown imposes many challenges to patients with diabetes. We aimed to assess the impact of COVID-19 lockdown on health-related behavior and disease control among patients with diabetes. MATERIALS AND

methodsA cross-sectional study was conducted among adults with diabetes attending a diabetes clinic in Colombo, Sri Lanka in June-July 2020. Lifestyle and disease control changes before and during the lockdown, were determined using an interviewer-administered questionnaire and review of medical records.

resultsAmong 1727 participants mean HbA1c decreased by 0.30% (95% CI 0.24-0.36, p < 0.001). HbA1c improved in 37.6% but deteriorated in 18.8%. Male sex (OR 1.36, 95% CI 1.10-1.67), better education (OR 1.10, 95% CI 1.01-1.20) and being employed (OR 1.08, 95% CI 1.00-1.16) were sociodemographic predictors of improved control. Better dietary adherence (OR 1.55, 95% CI 1.13-2.12), night-time sleep (OR 1.46, 95% CI 1.13-1.88) and indoor exercise (OR 1.62, 95% CI 1.23-2.07) were behavioural determinants of improved glycaemia. Decreases in self-monitoring of blood glucose (OR 1.45, 95% CI 1.09-1.93), exercise (OR 1.7, 95% CI 1.32-2.20), medication use (OR 1.95, 95% CI 1.37-2.78), dietary adherence (OR 1.72, 95% CI 1.32-2.26) and family income (OR 1.45, 95% CI 1.12-1.88) predicted worsening glycaemia. Only 4.1% used telehealth services; 83.1% of them reported good satisfaction.

conclusionsMean HbA1c improved during the lockdown. Overall, 37.6% of participants improved their glycaemic control. Well-educated employed men were more likely to improve glycaemic status. Improving diabetes control through healthy lifestyle practices and self-monitoring are feasible even in resource limited settings.

Indexed as

COVID-19Diabetes MellitusAdultAsiaBlood GlucoseCommunicable Disease ControlCross-Sectional StudiesHumansMaleSARS-CoV-2Blood GlucoseCOVID-19DiabetesLifestyleSelf-monitoring of blood glucoseSouth Asia

Identifiers

PMID34974994
PMCPMC8651510
OpenAlexW4200194941

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.